merged_medicare-prices-ozempic-wegovy.txt
<question_number>1</question_number>
<answer>N/A</answer>

<question_number>2</question_number>
<answer>N/A</answer>

<question_number>3</question_number>
<answer>N/A</answer>

<question_number>4</question_number>
<answer>N/A</answer>

<question_number>5</question_number>
<answer>N/A</answer>

<question_number>6</question_number>
<answer>N/A</answer>

<question_number>7</question_number>
<answer>N/A</answer>

<question_number>8</question_number>
<answer>consuming healthy food</answer>
<other>The article states that Robert F. Kennedy Jr. "has been vocal in his criticism of Ozempic, which he says is inferior to consuming healthy food"</other>

<question_number>9</question_number>
<answer>N/A</answer>

<question_number>10</question_number>
<answer>N/A</answer>

<question_number>11</question_number>
<answer>November</answer>
<other>The article states "The law gives the Trump administration a deadline of the end of November to announce Medicare's new prices for Ozempic, Wegovy and the other drugs on Friday's list."</other>

<question_number>12</question_number>
<answer>Robert F. Kennedy Jr.</answer>
<other>The article states "Mr. Trump's pick for health secretary, Robert F. Kennedy Jr., will lead the negotiations if he wins confirmation. He has been vocal in his criticism of Ozempic, which he says is inferior to consuming healthy food"</other>

<question_number>13</question_number>
<answer>2027</answer>
<other>The article states "The nonpartisan Congressional Budget Office projected that thanks to the negotiations, Medicare's prices for semaglutide products 'will fall substantially beginning in 2027.'"</other>

<question_number>14</question_number>
<answer>lower prices closer to what the government pays for semaglutide</answer>
<other>The article states "That would also open the door to lower prices for competing obesity drugs like Eli Lilly's Zepbound. Pharmacy benefit managers, which negotiate drug prices, would have more leverage to demand lower prices closer to what the government pays for semaglutide."</other>

<question_number>15</question_number>
<answer>weight loss alone</answer>
<other>The article states "the agency is not allowed to cover Wegovy for weight loss alone."</other>

<question_number>16</question_number>
<answer>Inflation Reduction Act</answer>
<other>The article states the drugs "were selected for price negotiations along with more than a dozen other widely used or costly medications as part of a program created by the Inflation Reduction Act, President Biden's signature legislation."</other>

<question_number>17</question_number>
<answer>Novo Nordisk</answer>
<other>The article states "The drugs, made by Novo Nordisk, were selected for price negotiations..."</other>

<question_number>18</question_number>
<answer>U.S. Agency for International Development</answer>
<other>The article states "U.S.A.I.D.: Trump directly called for the closure of the U.S. Agency for International Development, the government's main provider of global humanitarian and development aid, just hours before most of its staff were expected to be suspended with pay or laid off."</other>

<question_number>19</question_number>
<answer>Biden administration</answer>
<other>The article states "Late last year, the Biden administration separately proposed that the federal government expand coverage of weight-loss drugs to millions of Americans, though it's unclear if the Trump administration will carry out the proposal."</other>

<question_number>20</question_number>
<answer>more leverage to demand lower prices closer to what the government pays for semaglutide</answer>
<other>The article states "Pharmacy benefit managers, which negotiate drug prices, would have more leverage to demand lower prices closer to what the government pays for semaglutide."</other>